Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Key Highlights
- ➤Celularity (CELU) becomes exclusive U.S. finish-manufacturing partner for Vesalius peptide APIs
- ➤Collaboration uses Celularity’s Florham Park facility for purification, testing and cGMP manufacturing
- ➤Parties plan potential supply to licensed U.S. compounding pharmacies, subject to FDA and legal requirements
- ➤Agreement creates potential Celularity revenue opportunity but includes no disclosed financial terms
- ➤GLP-1 receptor agonists and other weight-loss peptides are excluded from the collaboration
Expert Statements
Robert J. Hariri, M.D., Ph.D., Founder, Chairman and Chief Executive Officer of Celularity
“Peptides represent an important category of products which can work to augment the clinical utility of conventional therapeutics, and we believe can complement our regenerative cellular products.”
Robert J. Hariri, M.D., Ph.D., Founder, Chairman and Chief Executive Officer of Celularity
“We have invested in a purpose-built U.S. facility and assembled a team with experience manufacturing complex medicines. As such, our collaboration with Vesalius represents an important business opportunity for Celularity and a practical extension of our regenerative longevity strategy.”
Pradeep Albert, CEO of Vesalius
“We selected Celularity because its facility, technical personnel and experience manufacturing complex biological products provide a strong foundation for our peptide API sourcing plans.”
Pradeep Albert, CEO of Vesalius
“Celularity’s capabilities complement our Peptual platform and commercialization strategy. Together, we aim to establish a U.S. domestic supply platform supported by documented manufacturing processes, defined quality specifications and traceability from supplier inputs through final API release.”
Micheal Roizen, M.D., Former head of Wellness at Cleveland Clinic and Chief Scientific Advisor at Vesalius
“The healthcare community deserves transparency about where the ingredients in medications originate and how their quality has been evaluated.”
Micheal Roizen, M.D., Former head of Wellness at Cleveland Clinic and Chief Scientific Advisor at Vesalius
“When the original manufacturer is unclear or testing records are incomplete, physicians and patients are left with questions that should be answered before a product is used.”
Micheal Roizen, M.D., Former head of Wellness at Cleveland Clinic and Chief Scientific Advisor at Vesalius
“Vesalius’s collaboration with Celularity is intended to bring greater visibility and accountability to that supply chain. That is an important foundation for responsible progress in peptide medicine.”
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity to serve as the exclusive partner for the finish manufacturing of Vesalius’s Peptual peptide APIs, supporting Vesalius’s expansion into pharmaceutical ingredient supply
Get started
Create a free account to read the full story.